Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Medications for PCOS don't seem to raise heart disease risk.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A natural steroid in the body may protect against eye damage in glaucoma.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

PPAR activation can improve diabetic wound healing by enhancing blood vessel function.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

GLP-1 agonists may help treat certain skin conditions.

GLP-1 and GLP-1/GIP agonists may increase the risk of hair loss.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Prophylactic pilocarpine may not prevent angle closure in the other eye.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.